Proofreading Enzyme Structure Revealed: A Leap Toward Potent COVID‑19 Antivirals
# Inside the Virus’s Error‑Correction Machine: A Structural Breakthrough Researchers have unveiled the first atomic‑resolution structure of SARS‑CoV‑2’s proofreading exoribonuclease, delivering an unprecedented view of how the virus removes erroneous nucleotides during replication. Using cryo‑electron microscopy, the team captured the enzyme in several distinct conformations, revealing the precise motions that enable excision of mis‑incorporated bases. The work explains the limited efficacy of many existing nucleotide‑analog antivirals and provides a concrete blueprint for designing next‑generation compounds that can resist the viral “proofreading” shield. ## Key Takeaways - Atomic‑resolution cryo‑EM maps of the SARS‑CoV‑2 exoribonuclease (nsp14‑nsp10 complex) have been published. - Multiple structural states illustrate the stepwise mechanism by which the enzyme detects and excises mismatched nucleotides. - The data clarify why several current antiviral nucleoside analogs are removed, undermining their therapeutic potency. - The resolved structure serves as a template for engineering nucleotide analogs that evade excision, opening a path to more robust antivirals. - Insight into the proofreading machinery accelerates rational drug design and strengthens preparedness against current and future coronavirus threats. #SARSCoV2 #ProofreadingEnzyme #Exoribonuclease #CryoEM #AntiviralDesign #NucleotideAnalogs #DrugResistance #MolecularStructure #COVID19Research #newsababil360 [Read Full Article](https://news.ababil360.com/proofreading-enzyme-structure-revealed-a-leap-toward-potent-covid-19-antivirals/)
